Literature DB >> 10438353

Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters.

T R Sterling1, C M Lyles, D Vlahov, J Astemborski, J B Margolick, T C Quinn.   

Abstract

Cross-sectional studies have demonstrated lower plasma human immunodeficiency virus type 1 (HIV-1) RNA virus levels (VLs) in women than in men, but it is unknown whether this sex difference is present at the time of seroconversion and throughout the course of infection. A nested case-control study was performed among HIV-1 seroconverters within a cohort of injection drug users. Plasma VL was determined longitudinally among both rapid progressors to AIDS (24 patients) and nonprogressors (47 controls). The initial median VL among female patients (n=10) was 14,918 copies/mL, compared with 148,354 copies/mL among male patients (n=14; P=.001); median plasma VL also tended to be lower among female (n=10) than among male controls (n=37; 11,917 vs. 61,311 copies/mL; P=.08). VL increased more rapidly over time in women than in men and subsequently converged in patients and controls, respectively. Understanding the mechanisms responsible for the sex difference in VL may provide insight into HIV-1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438353     DOI: 10.1086/314967

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  55 in total

1.  Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues.

Authors:  Leandro R Jones; Franco Moretti; Andrea Y Calvo; Darío A Dilernia; Julieta M Manrique; Manuel Gómez-Carrillo; Horacio Salomón
Journal:  AIDS Res Hum Retroviruses       Date:  2011-11-22       Impact factor: 2.205

2.  17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Authors:  Erika L Szotek; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

3.  CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.

Authors:  Amie L Meditz; Joy M Folkvord; Ngan H Lyle; Kristina Searls; Yolanda S Lie; Eoin P Coakley; Martin McCarter; Samantha Mawhinney; Elizabeth Connick
Journal:  J Infect Dis       Date:  2013-10-31       Impact factor: 5.226

4.  Demographics and natural history of HIV-1-infected spontaneous controllers of viremia.

Authors:  Otto O Yang; William G Cumberland; Robert Escobar; Diana Liao; Kara W Chew
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

5.  Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral Therapy.

Authors:  Shane D Falcinelli; Bonnie E Shook-Sa; Morgan G Dewey; Sumati Sridhar; Jenna Read; Jennifer Kirchherr; Katherine S James; Brigitte Allard; Simon Ghofrani; Erin Stuelke; Caroline Baker; Nadia R Roan; Joseph J Eron; JoAnn D Kuruc; Catalina Ramirez; Cynthia Gay; Katie R Mollan; David M Margolis; Adaora A Adimora; Nancie M Archin
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

6.  High HIV-1 RNA Among Newly Diagnosed People in Botswana.

Authors:  Vladimir Novitsky; Melanie Prague; Sikhulile Moyo; Tendani Gaolathe; Mompati Mmalane; Etienne Kadima Yankinda; Unoda Chakalisa; Refeletswe Lebelonyane; Nealia Khan; Kathleen M Powis; Erik Widenfelt; Simani Gaseitsiwe; Scott L Dryden-Peterson; Molly Pretorius Holme; Victor De Gruttola; Pam Bachanas; Joseph Makhema; Shahin Lockman; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2018-01-17       Impact factor: 2.205

7.  Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men.

Authors:  Catherine N Le; Paula Britto; Sean S Brummel; Risa M Hoffman; Jonathan Z Li; Patricia M Flynn; Taha E Taha; Anne Coletti; Mary Glenn Fowler; Ronald J Bosch; Rajesh T Gandhi; Karin L Klingman; James A McIntyre; Judith S Currier
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

8.  Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.

Authors:  Susan A Fiscus; Susan Cu-Uvin; Abel Tilahun Eshete; Michael D Hughes; Yajing Bao; Mina Hosseinipour; Beatriz Grinsztejn; Sharlaa Badal-Faesen; Joan Dragavon; Robert W Coombs; Ken Braun; Laura Moran; James Hakim; Timothy Flanigan; N Kumarasamy; Thomas B Campbell
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

Review 9.  Sex-based differences in HIV type 1 pathogenesis.

Authors:  Marylyn M Addo; Marcus Altfeld
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

10.  Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.

Authors:  Alan Landay; Lorie Benning; James Bremer; Barbara Weiser; Harold Burger; Marek Nowicki; Andrea Kovacs
Journal:  J Infect Dis       Date:  2003-07-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.